| Fiscal period | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Period End Date | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2011 |
|---|
| Sales | 844.45 | 627.92 | 582.38 | 470.93 | 388.67 | 333.07 | 282.54 | 238.09 | 213.81 | 196.52 |
| Total Revenues | 844.45 | 627.92 | 582.38 | 470.93 | 388.67 | 333.07 | 282.54 | 238.09 | 213.81 | 196.52 |
| Cost of Revenue | 378.50 | 281.60 | 259.71 | 212.65 | 177.79 | 152.90 | 129.92 | 110.19 | 100.67 | 94.93 |
| Cost of revenues: Product cost | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of revenues: Stock-based compensation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | 465.95 | 346.33 | 322.67 | 258.28 | 210.87 | 180.17 | 152.62 | 127.90 | 113.15 | 101.59 |
| Research and development | 137.60 | 107.76 | 93.46 | 82.36 | 73.64 | 65.79 | 58.59 | 49.73 | 48.80 | 44.52 |
| Stock-based compensation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative | 161.67 | 133.54 | 113.80 | 97.26 | 83.01 | 72.31 | 66.76 | 54.62 | 50.02 | 40.28 |
| Lease abandonment | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Patent litigation settlement | (7.80) | (2.46) | (1.92) | (1.24) | 0.23 | -- | 8.03 | -- | 2.95 | -- |
| Provision for litigation expense | -- | -- | -- | -- | -- | (1.00) | -- | 0.37 | -- | (3.38) |
| Total Operating Expenses | 307.07 | 243.76 | 209.18 | 180.86 | 156.43 | 139.10 | 117.32 | 103.99 | 95.87 | 88.18 |
| Operating Income (Loss) | 158.88 | 102.56 | 113.49 | 77.42 | 54.45 | 41.07 | 35.30 | 23.92 | 17.28 | 13.42 |
| Interest and other expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest and other income (expense) | 10.46 | 10.56 | 4.99 | 5.52 | 2.82 | 1.42 | 1.09 | 0.09 | 0.61 | 0.31 |
| Income (loss) before income taxes | 169.34 | 113.12 | 118.48 | 82.94 | 57.26 | 42.49 | 36.39 | 24.01 | 17.89 | 13.73 |
| Income (loss) before income tax: United States | 39.29 | (4.13) | (13.15) | (19.12) | -- | (0.25) | 3.17 | (2.31) | 0.81 | -- |
| Income (loss) before income tax: International | 130.06 | 117.25 | 131.63 | 102.06 | -- | 42.74 | 33.22 | 26.32 | 17.08 | -- |
| Current- Foreign | -- | -- | -- | 1.97 | 2.01 | 1.21 | -- | 1.05 | 1.30 | -- |
| Current: Federal | 2.84 | 1.68 | 11.02 | 31.03 | 2.53 | 6.04 | 0.02 | 0.08 | 0.84 | -- |
| Current: State | 0.00 | 0.01 | 0.00 | 0.00 | -- | 0.00 | (0.03) | 0.07 | 0.00 | -- |
| Deferred: Federal | (1.22) | (0.21) | (0.80) | (15.43) | -- | -- | -- | -- | -- | -- |
| Deferred: State | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred: Foreign | (0.47) | (0.30) | (0.01) | 0.17 | 0.00 | 0.06 | (0.04) | (0.09) | (0.01) | -- |
| Income tax provision (benefit) | 4.97 | 4.28 | 13.21 | 17.74 | 4.54 | 7.32 | 0.90 | 1.11 | 2.13 | 0.43 |
| Less: Valuation allowance | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income (loss) before preferred dividend | 164.38 | 108.84 | 105.27 | -- | -- | -- | -- | -- | -- | -- |
| Accretion of redeemable convertible preferred stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (loss) Available to Common Shareholders | 164.38 | 108.84 | 105.27 | 65.20 | 52.72 | 35.17 | 35.50 | 22.90 | 15.76 | 13.30 |
| Net Earnings Per Share (Basic) | 3.67 | 2.52 | 2.49 | 1.58 | 1.30 | 0.89 | 0.92 | 0.61 | 0.45 | 0.39 |
| Net Earnings Per Share (Diluted) | 3.50 | 2.38 | 2.36 | 1.50 | 1.26 | 0.86 | 0.89 | 0.59 | 0.43 | 0.38 |
| Weighted Average Shares Outstanding (Basic) | 44.84 | 43.17 | 42.25 | 41.35 | 40.44 | 39.47 | 38.69 | 37.39 | 34.87 | 34.05 |
| Weighted Average Shares Outstanding (Diluted) | 47.01 | 45.76 | 44.60 | 43.58 | 41.92 | 40.87 | 39.79 | 38.62 | 36.25 | 35.16 |